As Australian shares follow Wall Street into the red, with geopolitical tensions and economic uncertainties casting a shadow over market sentiment, investors are increasingly seeking refuge in more stable sectors like consumer staples. In such volatile times, growth companies with high insider ownership can offer a compelling investment narrative as they often signal strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In Australia

Name Insider Ownership Earnings Growth
Torque Metals (ASX:TOR) 18.6% 94.2%
Starpharma Holdings (ASX:SPL) 15.6% 91.8%
SKS Technologies Group (ASX:SKS) 28.2% 39.5%
Pinnacle Investment Management Group (ASX:PNI) 25% 21.1%
Magnetic Resources (ASX:MAU) 33.6% 124.2%
Forrestania Resources (ASX:FRS) 38.3% 113.3%
Echo IQ (ASX:EIQ) 19.7% 108.8%
Austral Resources Australia (ASX:AR1) 19.4% 38.7%
Adveritas (ASX:AV1) 17.9% 108.4%
Advanced Energy Minerals (ASX:AEM) 35.1% 48.4%

Click here to see the full list of 105 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and internationally with a market cap of A$446.29 million.

Operations: The company’s revenue primarily comes from its biopharmaceutical sector, which generated A$96.30 million.

Insider Ownership: 10.2%

Earnings Growth Forecast: 24.9% p.a.

Clinuvel Pharmaceuticals, with substantial insider ownership, is poised for growth with its earnings forecasted to increase significantly at 24.9% annually, outpacing the Australian market’s 12%. The company trades at a significant discount to its estimated fair value and expects revenue growth of 17.8% per year. Recent developments include European Medicines Agency’s advice on Clinuvel’s Phase III study for SCENESSE in vitiligo treatment, highlighting potential advancements in their product pipeline.

ASX:CUV Ownership Breakdown as at Jun 2026
ASX:CUV Ownership Breakdown as at Jun 2026

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Energy One Limited provides software products, outsourced operations, and advisory services to wholesale energy, environmental, and carbon trading markets in Australasia and Europe, with a market cap of A$397.13 million.

Operations: The company generates revenue of A$67.01 million from its energy software industry segment, serving wholesale energy, environmental, and carbon trading markets in Australasia and Europe.

Insider Ownership: 22.5%

Earnings Growth Forecast: 26.4% p.a.

Energy One, with significant insider ownership, is set for robust growth as its earnings are forecast to rise by 26.4% annually, surpassing the Australian market’s 12%. Despite a recent CFO transition, new appointee Jason Mabee brings extensive experience to support this growth trajectory. The company’s revenue is expected to grow at 12.2% per year, faster than the market average of 6.1%, although its Return on Equity remains below benchmark expectations in three years.

ASX:EOL Earnings and Revenue Growth as at Jun 2026
ASX:EOL Earnings and Revenue Growth as at Jun 2026

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lindian Resources Limited, with a market cap of A$1.55 billion, is involved in the exploration of mineral properties across Tanzania, Guinea, Malawi, and Australia through its subsidiaries.

Operations: Lindian Resources Limited currently does not report any revenue segments in its financial disclosures.

Insider Ownership: 14.6%

Earnings Growth Forecast: 83.9% p.a.

Lindian Resources, with significant insider ownership, is poised for substantial growth as its revenue is forecast to increase by 138.8% annually, outpacing the Australian market’s 6.1%. Despite a recent net loss of A$8.79 million, the company is expected to become profitable within three years. Recent executive appointments, including CFO Derek Bideshi and General Counsel Anastasia Gotjamanos, strengthen Lindian’s leadership as it advances its Kangankunde Rare Earths Project and downstream processing initiatives.

ASX:LIN Earnings and Revenue Growth as at Jun 2026
ASX:LIN Earnings and Revenue Growth as at Jun 2026

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.
It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.
All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *